Resistance in Malignant Tumors: Can Resistance Assays Optimize Cytostatic Chemotherapy?

Publisher： Karger

E-ISSN： 1423-0313|81|3|196-203

ISSN： 0031-7012

Source： Pharmacology, Vol.81, Iss.3, 2008-01, pp. : 196-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resistance to Chemotherapy in Cancer: A Complex and Integrated Cellular Response

By  

Pharmacology, Vol. 81, Iss. 4, 2008-02 ,pp. : 275-300

Karger

Access to resources Recommend Favorite

The Role of Epigenetics in Resistance to Cisplatin Chemotherapy in Lung Cancer

By O'Byrne Kenneth J.   Barr Martin P.   Gray Steven G.  

Cancers, Vol. 3, Iss. 1, 2011-03 ,pp. : 1426-1453

MDPI

Access to resources Recommend Favorite

Chemotherapy Modulates Intestinal Immune Gene Expression Including Surfactant Protein-D and Deleted in Malignant Brain Tumors 1 in Piglets

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 204-216

Karger

Access to resources Recommend Favorite

Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells

By Schmalz Philip G.R.   Shen Michael J.   Park John K.  

Cancers, Vol. 3, Iss. 1, 2011-02 ,pp. : 621-635

MDPI

Access to resources Recommend Favorite

The Reversal of Drug-Resistance in Tumors Using a Drug-Carrying Nanoparticular System

By Oh Kyung Taek   Baik Hye Jung   Lee A Hyeong   Oh Young Taik   Youn Yu Seok   Lee Eun Seong  

International Journal of Molecular Sciences, Vol. 10, Iss. 9, 2009-08 ,pp. : 3776-3792

MDPI

Access to resources Recommend Favorite